Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

Paeds SAQsgrowth-development-and-behaviour

Paeds SAQs · growth-development-and-behaviour

Normal growth from fetal life through adolescence — formative SAQs

Formative SAQs on ICP growth physiology, chart selection and normal-variant versus pathological short stature.

20 marks30 min
On this page & tools

Target exams

RACP General PaediatricsMRCPCH TheoryMRCPCH Clinical

Target exams

RACP General PaediatricsMRCPCH TheoryMRCPCH Clinical
Prompt
Normal growth from fetal life through adolescence

SAQ 1 (10)

A 7-year-old boy is referred because he is “the smallest in his class.” Height is on the 3rd centile. Weight is on the 10th. He tracks parallel to the 3rd height centile over 18 months. Both parents are short. Examination is normal. Puberty has not begun. [6]

  1. Outline the infancy–childhood–puberty model of linear growth and state which phase dominates at age 7. (3) [3]
  2. List four features that support familial short stature rather than pathological short stature. (4) [6]
  3. State when idiopathic short stature is an appropriate residual label. (3) [5]

Model answer

ICP at age 7. Infancy growth is largely nutrition-driven; childhood growth depends on the GH–IGF-1 axis; puberty adds sex-steroid drive and a spurt. At age 7, childhood-phase GH–IGF-1 biology dominates. [3]

Familial short stature features. Short parents / mid-parental height consistent with current channel; normal growth velocity (parallel tracking); normal examination without disproportion or dysmorphism; delayed evaluation not forced by red flags (systemic symptoms, falling height velocity). Bone age often near chronological age in classic familial short stature teaching, in contrast to constitutional delay. [6]

ISS. Idiopathic short stature is residual after complete evaluation for short stature, including exclusion of alternative causes and stimulated GH testing in consensus frameworks — not a first-glance clinic label for every child near the 3rd centile. [5]

SAQ 2 (10)

You review serial growth in clinic. [1]

  1. Distinguish a growth standard from a growth reference, naming one example of each. (3) [1] [2]
  2. In the US recommendation set, which charts are preferred under 24 months and from 2 years? What WHO screening extremes are recommended (±SD)? (3) [2]
  3. Define SGA versus fetal growth restriction and state why catch-up surveillance matters. (4) [4]

Model answer

Standard vs reference. A standard describes how children should grow under favourable conditions (WHO Child Growth Standards 0–5 years). A reference describes how a population did grow (CDC 2000 charts; also WHO 5–19 as a reference for older children). [1] [2]

US chart allocation. WHO charts for ages under 24 months; CDC charts from 2 years. When screening on WHO charts, use about ±2 SD (near 2.3rd and 97.7th percentiles). [2]

SGA vs FGR. SGA is a birth-size label (commonly weight below a gestation- and sex-specific threshold such as the 10th centile). FGR describes restricted fetal growth as a process. Many SGA infants catch up; those who do not need structured etiology review and long-term follow-up per international SGA consensus principles. [4]

References

  1. [1]WHO Multicentre Growth Reference Study Group WHO Child Growth Standards based on length/height, weight and age. Acta paediatrica (Oslo, Norway : 1992). Supplement, 2006.PMID 16817681
  2. [2]Grummer-Strawn LM Use of World Health Organization and CDC growth charts for children aged 0-59 months in the United States. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 2010.PMID 20829749
  3. [3]Karlberg J Analysis of linear growth using a mathematical model. I. From birth to three years. Acta paediatrica Scandinavica, 1987.PMID 3604665
  4. [4]Hokken-Koelega ACS International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood. Endocrine reviews, 2023.PMID 36635911
  5. [5]Cohen P Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. The Journal of clinical endocrinology and metabolism, 2008.PMID 18782877
  6. [6]Barstow C Evaluation of Short and Tall Stature in Children. American family physician, 2015.PMID 26132126